Revenue, last quarter
$1.1M
−63.1% vs same quarter last year
Net income
−$46.5M
−166.4% vs same quarter last year
EPS, diluted
−$0.46
−84% vs same quarter last year
Operating cash flow
−$14M
−128% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $14.2M | −$49.6M |
| FY24 | $11M | −$57.5M |
| FY23 | $19M | −$10M |
| FY22 | $39.9M | $17.9M |
| FY21 | $589K | −$56.7M |
| FY20 | $0 | −$24.6M |
| FY19 | $3M | −$6.2M |
| FY18 | - | −$14.4M |
| FY17 | - | −$25.3M |
| FY16 | - | −$9.3M |
| FY15 | - | −$14.4M |
| FY14 | - | −$18.5M |
| FY13 | $0 | −$9.5M |
| FY12 | $0 | −$6.2M |
| FY11 | $0 | −$11.3M |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −271.9% | −349.3% |
| FY24 | −564.7% | −523.4% |
| FY23 | −55.5% | −52.4% |
| FY22 | 45.7% | 44.9% |
| FY21 | −3854.8% | −9625.3% |
| FY20 | - | - |
| FY19 | −139.8% | −205.6% |
| FY18 | - | - |
| FY17 | - | - |
| FY16 | - | - |
| FY15 | - | - |
| FY14 | - | - |
| FY13 | - | - |
| FY12 | - | - |
| FY11 | - | - |
- Opus Genetics
- Healthcare median
Show the numbers
| Year | Opus Genetics | Healthcare median |
|---|---|---|
| FY25 | −349.3% | −30.6% |
| FY24 | −523.4% | −47% |
| FY23 | −52.4% | −58% |
| FY22 | 44.9% | −80.4% |
| FY21 | −9625.3% | −71.8% |
| FY20 | - | −62.2% |
| FY19 | −205.6% | −46.2% |
| FY18 | - | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |
| FY15 | - | −37.8% |
| FY14 | - | −35.5% |
| FY13 | - | −37.1% |
| FY12 | - | −29.1% |
| FY11 | - | −27.9% |